CTRI/2012/08/002916
Recruiting
未知
Indications for 18[F] FDG PET CT (Positron emission Tomography- Computed Tomograpy) in esophageal cancer- Study based on the patients referred to Nuclear medicine Department,Max Super Speciality Hospital Saket New Delhi.
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- A
- Enrollment
- 200
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Histologically proven esophageal carcinoma (squamous cell carcinoma or Adenocarcinoma)
- •PET\-CT performed at Max hospital
Exclusion Criteria
- •Patient clinical data not available
Investigators
Similar Trials
Not yet recruiting
Not Applicable
To study the role of FDG PET-CT in patients with lower back spinal pain for localization of active site generating pain and causing pain symptoms.CTRI/2022/09/046021ot applicable
Completed
Not Applicable
Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple MyelomaMultiple MyelomaNCT06170151IRCCS San Raffaele10
Unknown
Early Phase 1
18F-FDG PET/CT for IgG4-Related DiseaseAutoimmune DiseaseNCT01665196Peking Union Medical College Hospital100
Not yet recruiting
Not Applicable
Management and prognosis of breast cancer through FDG PET/CTHealth Condition 1: null- Breast Cancer (Retrospective data of Breast Cancer Patients will be collected)CTRI/2012/09/002966ot applicable Thesis Protocol500
Unknown
Phase 4
Evaluation of PET CT in the Management of Patients With Crohn's Disease.Crohn's DiseaseNCT00731809Rabin Medical Center50